Solidarity II global serologic study for COVID-19, WHO

Solidarity II is a global collaboration led by the World Health Organization that promotes the implementation of serological surveys of SARS-CoV-2. Solidarity II provides a collaborative environment for public health agencies and academic institutions around the world to work together to answer some of the most urgent questions about the COVID-19 pandemic. Understanding the occurrence of infection with SARS-CoV-2 infection is critical for the world to know how frequently infection occurs among different populations, how many people have had mild or asymptomatically infection, how many people have been infected but may not have been identified by routine disease surveillance, and what proportion of the population may be immune from infection by SARS-CoV-2 in the future.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news